SCHEMBL6836078

SCHEMBL6836078

CCCCOC(=O)CN1CCC(N)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GNAI3 P08754 2/20 0.46
GNAO1 P09471 2/20 0.46
GNAI1 P63096 2/20 0.46
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
HRH2 P25021 1/20 0.41
HRH1 P35367 1/20 0.41
ALDH1A1 P00352 4/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
NAAA Q02083 1/20 0.40
POLB P06746 2/20 0.39
LMNA P02545 1/20 0.39
SPHK1 Q9NYA1 1/20 0.38
KDM4E B2RXH2 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
TSHR P16473 1/20 0.38
S1PR5 Q9H228 1/20 0.38
CYP2D6 P10635 1/20 0.38
RAB9A P51151 1/20 0.38
ATM Q13315 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14611251 0.95 GNAI3 (0.49) GNAI3GNAO1GNAI1ALDH1A1SMN1; SMN2
Hydrochloric Acid SCHEMBL7585696 0.89 GNAI3 (0.44) GNAI3GNAO1GNAI1MEN1KMT2A
SCHEMBL8259120 0.86 HPGD (0.49) MEN1KMT2AALDH1A1SMN1; SMN2NAAA
SCHEMBL30839344 0.85 MEN1 (0.49) MEN1KMT2AALDH1A1SMN1; SMN2NAAA
SCHEMBL16607366 0.85 MEN1 (0.49) MEN1KMT2AALDH1A1SMN1; SMN2NAAA
SCHEMBL13713449 0.84 GNAI3 (0.54) GNAI3GNAO1GNAI1HRH2HRH1
SCHEMBL6992740 0.83 SMYD3 (0.44) GNAI3GNAO1GNAI1KMT2AALDH1A1
SCHEMBL7421244 0.83 S1PR5 (0.54) MEN1KMT2AALDH1A1SMN1; SMN2POLB
SCHEMBL12842703 0.83 ALDH1A1 (0.38) GNAI3GNAO1GNAI1MEN1KMT2A
SCHEMBL8169180 0.82 SMN1; SMN2 (0.41) MEN1KMT2AALDH1A1SMN1; SMN2NAAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007020261-A2 SELECTED CGRP ANTAGONISTS, METHODS FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-02-22 WO disclosed
US-20040087622-A1 Benzamide derivative and medicament containing the same KATO HIDEO (JP) 2004-05-06 US disclosed
CN-1126738-C Benzamide derivatives and drugs containing the same HOKURIKU PHARMACEUTICAL (JP) 2003-11-05 CN disclosed
US-6638951-B1 Medicament has excellent enhancing action on gastrointestinal tract motility, and is orally available with reduced side effects, the agent for therapeutic treatment of digestive diseases, an agent for improving function of gastrointestinal HOKURIKU SEIYAKU CO., LTD. (JP) 2003-10-28 US disclosed
EP-1149832-B1 BENZAMIDE DERIVATIVES AND DRUGS CONTAINING THE SAME HOKURIKU PHARMACEUTICAL (JP) 2003-01-02 EP disclosed
CN-1339026-A Benzamide derivatives and drugs containing the same HOKURIKU PHARMACEUTICAL (JP) 2002-03-06 CN disclosed
EP-1149832-A1 BENZAMIDE DERIVATIVES AND DRUGS CONTAINING THE SAME HOKURIKU SEIYAKU CO., LTD. (JP) 2001-10-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040087622-A1 Benzamide derivative and medicament containing the same SLC10A2, FABP2, HDAC6 GNAI3 938/4885GNAO1 921/4885GNAI1 582/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.